Phase 2 Leukaemia Trial, Recruiting NCT04440267 Sponsor: Institute of Hematology & Blood Diseases Hospital, China Condition: Leukaemia
Back to Leukaemia

Phase 2 Leukaemia Trial, Recruiting

NCT04440267
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 14 years or older who have been diagnosed with acute leukemia of ambiguous lineage (a type of blood cancer that has features making it difficult to classify as one specific type)
  • People whose general physical functioning is rated at a level of 2 on a standard medical scale, meaning they are able to care for themselves but may not be able to do heavy physical activity (confirm with trial site)
  • People whose liver, kidney, and pancreas are working at an adequate level, as shown by specific blood test results falling within defined ranges
  • People whose heart is pumping effectively, with a heart function score of 45% or above on a specific heart scan (called a MUGA scan)
  • People whose blood levels of potassium, magnesium, and phosphorus are within normal ranges, or can be brought within normal ranges before the trial begins
  • People who are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • People with certain heart conditions, including a condition called Long QT syndrome (or a family history of it), a resting heart rate below 50 beats per minute, a heart pumping score below 45%, an abnormal heart rhythm reading on an ECG above a defined threshold, a heart attack within the past 12 months, unstable chest pain, heart failure, uncontrolled high blood pressure, or uncontrolled irregular heartbeat
  • People with another active cancer diagnosis that currently requires treatment
  • People with serious liver, pancreatic, or kidney disease
  • People with another severe or life-threatening medical condition
  • People who are currently pregnant
  • People who are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 86-22-23909120

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Registry
ClinicalTrials.gov
Start date
8 July 2020
Est. completion
20 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival (OS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov